GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Receivables Turnover

Australian Clinical Labs (ASX:ACL) Receivables Turnover : 5.38 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Australian Clinical Labs's Revenue for the six months ended in Dec. 2023 was A$337.8 Mil. Australian Clinical Labs's average Accounts Receivable for the six months ended in Dec. 2023 was A$62.7 Mil. Hence, Australian Clinical Labs's Receivables Turnover for the six months ended in Dec. 2023 was 5.38.


Australian Clinical Labs Receivables Turnover Historical Data

The historical data trend for Australian Clinical Labs's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Receivables Turnover Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23
Receivables Turnover
- 13.11 18.15 11.91

Australian Clinical Labs Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Receivables Turnover Get a 7-Day Free Trial 6.05 4.54 5.03 4.92 5.38

Competitive Comparison of Australian Clinical Labs's Receivables Turnover

For the Diagnostics & Research subindustry, Australian Clinical Labs's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Australian Clinical Labs's Receivables Turnover Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Australian Clinical Labs's Receivables Turnover falls into.



Australian Clinical Labs Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Australian Clinical Labs's Receivables Turnover for the fiscal year that ended in Jun. 2023 is calculated as

Receivables Turnover (A: Jun. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Jun. 2023 ) / ((Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Jun. 2023 )) / count )
=692.103 / ((64.888 + 51.352) / 2 )
=692.103 / 58.12
=11.91

Australian Clinical Labs's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

Receivables Turnover (Q: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Dec. 2023 ) / ((Accounts Receivable (Q: Jun. 2023 ) + Accounts Receivable (Q: Dec. 2023 )) / count )
=337.816 / ((51.352 + 74.138) / 2 )
=337.816 / 62.745
=5.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Australian Clinical Labs  (ASX:ACL) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Australian Clinical Labs Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Australian Clinical Labs (ASX:ACL) Business Description

Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines